Small Pharma Financials
DMTTFDelisted Stock | USD 0.05 0.0009 1.80% |
With this module, you can analyze Small financials for your investing period. You should be able to track the changes in Small Pharma individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Small |
Understanding current and past Small Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Small Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Small Pharma's assets may result in an increase in income on the income statement.
The data published in Small Pharma's official financial statements typically reflect Small Pharma's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Small Pharma's quantitative information. For example, before you start analyzing numbers published by Small accountants, it's essential to understand Small Pharma's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Small Pharma Stock Summary
Small Pharma competes with Cellectis, Covalon Technologies, and Mosaic Immunoengineerin. Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. The company was incorporated in 2015 and is headquartered in London, the United Kingdom. Small Pharma is traded on OTC Exchange in the United States.Instrument | USA OTC Stock View All |
Exchange | OTCQB Exchange |
Business Address | 6-8 Bonhill Street, |
Sector | Healthcare |
Industry | Biotechnology |
Benchmark | Dow Jones Industrial |
Website | www.smallpharma.com |
Phone | 44 2071 129118 |
Currency | USD - US Dollar |
Small Pharma Key Financial Ratios
There are many critical financial ratios that Small Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Small Pharma reports annually and quarterly.Small Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Small Pharma's current stock value. Our valuation model uses many indicators to compare Small Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Small Pharma competition to find correlations between indicators driving Small Pharma's intrinsic value. More Info.Small Pharma is rated # 4 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Small Pharma's earnings, one of the primary drivers of an investment's value.Small Pharma Market Pulse
Quote | 0.0509 |
Change(%) | 1.80 |
Change | 0.0009 |
Open | 0.05 |
Low | 0.0488 |
High | 0.0537 |
Volume | 0 |
Exchange | OTCQB |
Small Pharma February 2, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Small Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Small Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Small Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Small OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Small Pharma's daily price indicators and compare them against related drivers.
Downside Deviation | 8.82 | |||
Information Ratio | (0) | |||
Maximum Drawdown | 56.62 | |||
Value At Risk | (14.46) | |||
Potential Upside | 11.8 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Consideration for investing in Small OTC Stock
If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |